STK31 might serve as a potential target for cancer treatment given that inhibitory compounds targeting cell cycle kinases such as Polo-like kinase 1, Aurora-A and Aurora-B have been quite successful in treating cancers [12], [15], [39]. This evidence concerns the gene STK31 and cancer.